These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1123553)

  • 1. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis.
    Noble WC; White PM; Baker H
    J Invest Dermatol; 1975 Feb; 64(2):69-76. PubMed ID: 1123553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in erythrocytes of patients with psoriasis.
    Schrøder H; Foged EK
    Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose methotrexate kinetics in arthritis.
    Edelman J; Biggs DF; Jamali F; Russell AS
    Clin Pharmacol Ther; 1984 Mar; 35(3):382-6. PubMed ID: 6697645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients.
    Elango T; Dayalan H; Subramanian S; Gnanaraj P; Malligarjunan H
    Clin Chim Acta; 2012 Oct; 413(19-20):1652-6. PubMed ID: 22609260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.
    Christophidis N; Louis WJ; Lucas I; Moon W; Vajda FJ
    Cancer Chemother Pharmacol; 1981; 6(1):59-64. PubMed ID: 7273267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of small doses of methotrexate in patients with psoriasis.
    Kamel RS; al-Hakiem MH; Rademaker M; Meyrick Thomas RH; Munro DD
    Acta Derm Venereol; 1988; 68(3):267-70. PubMed ID: 2455425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of methotrexate.
    Shen DD; Azarnoff DL
    Clin Pharmacokinet; 1978; 3(1):1-13. PubMed ID: 346283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Subcutaneous methotrexate in psoriasis and psoriatic arthritis treatment].
    Szczerkowska-Dobosz A
    Wiad Lek; 2016; 69(4):675-679. PubMed ID: 27941209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate content in squamous cell carcinoma of the head and neck after low-dose methotrexate.
    Schifeling DJ; George T; McGuirt F; Capizzi RL; Kamen BA
    Med Pediatr Oncol; 1994; 22(2):88-90. PubMed ID: 8259106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of methotrexate in psoriasis therapy.
    Hendel J
    Dan Med Bull; 1985 Dec; 32(6):329-37. PubMed ID: 3908004
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal folate absorption in methotrexate treated psoriatic patients.
    Duhra P; Hodgson C; Martin JA; Stableforth PJ
    Br J Dermatol; 1988 Sep; 119(3):327-32. PubMed ID: 3179205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated nodulosis in a patient with psoriasis and arthritis during treatment with methotrexate.
    Berris B; Houpt JB; Tenenbaum J
    J Rheumatol; 1995 Dec; 22(12):2359-60. PubMed ID: 8835577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of administration of massive doses of methotrexate (50 g) with equimolar citrovorum factor rescue in adult patients.
    Reggev A; Djerassi I
    Cancer; 1988 Jun; 61(12):2423-8. PubMed ID: 3259154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
    Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some observations on the human pharmacology of methotrexate.
    Calvert AH; Bondy PK; Harrap KR
    Cancer Treat Rep; 1977 Dec; 61(9):1647-56. PubMed ID: 597817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.